Although FTD-GRN patients may show coexistent AD pathology [41], certain GRN variants have been suggested as the direct cause of AD [42] through several proposed mechanisms (i.e., Aβ clearance, tau phosphorylation, neuroinflammation), indicating shared pathways between AD and progranulin [43]. The gene discussed is MAPT; the disease is Alzheimer disease.